“…It occurs in the early phase of each dialysis session, mainly through the alternative pathway, and closely reflects dialysis membrane biocompatibility, which is observed in dialysis with cellulose membranes such as cuprophan, but not with synthetic membranes, such as polyacrilonitrile (Cheung, 1990). Activated complement-split products, C5a and C3a, were originally ascribed to neutrophil lung sequestration (Arnaout et al, 1985;Hakim et al, 1984), and are now endowed for several indices of dialysis-induced neutrophil and/or monocyte activation, including triggering of protease (Hö rl et al, 1985), reactive oxygen species (ROS) production by neutrophils (DescampsLatscha et al, 1991), and transcription (but not secretion) of the pro-inflammatory cytokines, interleukin-1 (IL-1) and TNF-␣ by monocytes (Schindler et al, 1990). The conjunction of massive generation of ROI in the face of a chronic deficiency of antioxidant systems (Cé ballos-Picot et al, 1996) and of a profound impairment in the balance between pro-inflammatory cytokines and their specific inhibitors (Descamps-Latscha et al, 1995) largely contribute to dialysis-related complications such as an increased rate of atherosclerosis and 2-microglobulin amyloidosis arthropathy (Descamps-Latscha, 1993).…”